Effects of Semaglutide on <scp>BMI</scp> and Cardiometabolic Profile in Adolescents With Variants in Monogenic Obesity‐Related Genes
Semaglutide was associated with significant reductions in BMI and cardiometabolic markers in adolescents (majority White) with dominant or known risk variants for monogenic obesity.
Authors
- Siobhán T. Pittock (ORCID: https://orcid.org/0000-0002-2616-7349)
- Ana Pérez Creo
- Oakley C. Olson (ORCID: https://orcid.org/0000-0002-0716-5380)
- Aida Nadim Lteif
- Alaa Al Nofal
- Mostafa Salama
- Seema Kumar
- Roland Hentz
- Doha Hassan
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Pediatric Obesity
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/ijpo.70091
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00